BioSpace News Archive

Astellas today announced the structure and operating model for its global Patient Centricity organization designed to support the development of innovative health solutions through a deep understanding of the patient experience, medical need and behavioral drivers of care.

A study co-authored by the U.S. Department of Health & Human Services and Millennium Health published in JAMA highlights a national increase in urine drug test positivity rates during COVID-19 for fentanyl, methamphetamine, cocaine, and heroin.

SGD Pharma today announces the launch of its new full packaging solution dedicated to the cannabidiol (CBD) oil market.

- Parnell Pharmaceuticals announced that it has developed what will be the first antiviral nasal spray in the United States. Nomovid™ Nasal Spray will be easy-to-use, low-cost and can be quickly made available over-the-counter for consumers. Nomovid is based upon a substance licensed by Parnell from New Mexico Tech Univers

Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian specialty pharmaceutical company, announced today that the Company has qualified to trade on the OTCQB market in the United States . Valeo’s shares have started trading today on the OTCQB under the symbol “VP

To help drive continued acceleration and growth, Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, announced the creation of a new Chief Commercial Officer position, as well as other key organizational and reporting changes within the business. All of the changes are effective October 1. Salman Mir, Executive Vice President and Chief Op

Across developed countries the ownership of companion or livestock animals of various known and exotic breeds has remained high since the last few decades.

Personalized medicines refer to those drugs that are made on the basis of intended patient groups or an individual patient carrying specific biomarkers.

Male infertility refers the male inability to cause pregnancy in a fertile female. It is majorly due to low sperm count, hormonal problem or presence of low number of motile sperms.

The global DNA polymerase market is estimated to show prominent growth in the upcoming years. This growth is attributed to growing research and development activities in all worldwide locations.